معرفی
Professor Jeremy Crook is a leading Biomedical Engineering academic affiliated with the University of Wollongong (2022-present), University of Sydney (2021-present) as Arto Hardy Family Professor and Chair of Biomedical Innovation, and Director of the Arto Hardy Family Biomedical Innovation Hub at Chris O'Brien Lifehouse Hospital. His research integrates stem cells, biomaterials, 3D bioprinting, and bioelectronics for advanced tissue engineering and regenerative medicine.
His scientific achievements include seminal work on muscarinic cholinergic receptors in schizophrenia pathophysiology, directly contributing to FDA approval of KarXT, the first antipsychotic drug targeting this mechanism. Current research focuses on electroceuticals for neural and cardiac tissue regeneration, with clinical applications in glioblastoma and spinal cord injury.
- 2019 Research Australia Health and Medical Research Frontiers Award
- NIH Fellows Award for Research Excellence (2001)
- International Society for Stem Cell Research Standards Task Force
Jeremy collaborates with clinical researchers to develop electrical stimulation technologies for in-body tissue regeneration and cancer therapeutics, while mentoring PhD students in neural tissue engineering, organoid modeling, and biofabrication. His work has secured major grants from NHMRC and ARC, including Ideas Grants and Centres of Excellence funding.
